Carbon phosphonitride (CPN) including tricyanophosphine (P(CN).sub.3), its pre-polymer (CPN-PP), and/or solid CPN (C.sub.3N.sub.3P) can serve as a useful additive for thermoset resins, resulting in improved thermal and mechanical properties.

Provided is a composite resin composition for steel plates for a fuel tank, including: 30 to 65% by weight of a polymer resin; 1 to 15% by weight of a curing agent; 2 to 20% by weight of a corrosion-resistant additive; 1 to 15% by weight of an adhesion promoting agent comprising a polyphosphazene polymer compound; and a residual solvent. A composite resin-coated steel plate for a fuel tank, and a manufacturing method for a composite resin-coated steel plate are provided.

A thermoplastic resin composition and a molded article formed of the same. The thermoplastic resin composition includes: about 100 parts by weight of a polycarbonate resin; about 5 to about 20 parts by weight of a rubber modified aromatic vinyl copolymer resin; about 0.5 to about 3 parts by weight of a maleic anhydride-grafted rubber polymer; about 50 to about 100 parts by weight of glass fibers; about 10 to about 30 parts by weight of barium sulfate; and about 5 to about 20 parts by weight of a phosphorus flame retardant. The thermoplastic resin composition can have high specific gravity and good properties in terms of impact resistance, weather resistance, flame retardancy, fluidity, and the like.

A thermoplastic resin composition and a molded article formed of the same. The thermoplastic resin composition includes: about 100 parts by weight of a polycarbonate resin; about 5 to about 20 parts by weight of a rubber modified aromatic vinyl copolymer resin; about 0.5 to about 3 parts by weight of a maleic anhydride-grafted rubber polymer; about 50 to about 100 parts by weight of glass fibers; about 10 to about 30 parts by weight of barium sulfate; and about 5 to about 20 parts by weight of a phosphorus flame retardant. The thermoplastic resin composition can have high specific gravity and good properties in terms of impact resistance, weather resistance, flame retardancy, fluidity, and the like.

The present invention provides a flame retardant composition having a high flame retarding effect and exceptional bleed-out suppression when added to a resin, and a flame-retardant thermoplastic resin composition that uses the same. This flame retardant composition includes a phosphoramidate compound (component (A)) having a specific structure, and a hindered amine compound (component (B)). This flame retardant composition furthermore includes, as needed, a compound (component (C)) having a 1,3,5-triazine structure or a 1,3,5-triazine fused ring structure. This flame-retardant thermoplastic resin composition includes the above component (A), the above component (B), and a thermoplastic resin (component (D)), and furthermore includes, as needed, the above component (C).

The present invention provides a flame retardant composition having a high flame retarding effect and exceptional bleed-out suppression when added to a resin, and a flame-retardant thermoplastic resin composition that uses the same. This flame retardant composition includes a phosphoramidate compound (component (A)) having a specific structure, and a hindered amine compound (component (B)). This flame retardant composition furthermore includes, as needed, a compound (component (C)) having a 1,3,5-triazine structure or a 1,3,5-triazine fused ring structure. This flame-retardant thermoplastic resin composition includes the above component (A), the above component (B), and a thermoplastic resin (component (D)), and furthermore includes, as needed, the above component (C).

The present invention is a flame retardant polyester resin composition that contains 3 to 74% by mass of a polybutylene terephthalate resin (A), 3 to 60% by mass of a polyethylene terephthalate resin (B1), 3 to 50% by mass of a copolyester resin (B2), 10 to 50% by mass of a halogen-free flame retardant (C), and 10 to 40% by mass of a glass fiber (D), wherein the copolyester resin (B2) is a polyester resin obtained by copolymerizing an ethylene terephthalate unit with at least one selected from the group consisting of neopentyl glycol, 1,2-propanediol, diethylene glycol, 1,4-cyclohexanedimethanol, and isophthalic acid, and that satisfies prescribed characteristics.

The present invention is a flame retardant polyester resin composition that contains 3 to 74% by mass of a polybutylene terephthalate resin (A), 3 to 60% by mass of a polyethylene terephthalate resin (B1), 3 to 50% by mass of a copolyester resin (B2), 10 to 50% by mass of a halogen-free flame retardant (C), and 10 to 40% by mass of a glass fiber (D), wherein the copolyester resin (B2) is a polyester resin obtained by copolymerizing an ethylene terephthalate unit with at least one selected from the group consisting of neopentyl glycol, 1,2-propanediol, diethylene glycol, 1,4-cyclohexanedimethanol, and isophthalic acid, and that satisfies prescribed characteristics.

The present invention relates in part to nucleic acids encoding proteins, nucleic acids containing non-canonical nucleotides, therapeutics comprising nucleic acids, methods, kits, and devices for inducing cells to express proteins, methods, kits, and devices for transfecting, gene editing, and reprogramming cells, and cells, organisms, and therapeutics produced using these methods, kits, and devices. Methods for inducing cells to express proteins and for reprogramming and gene-editing cells using RNA are disclosed. Methods for producing cells from patient samples, cells produced using these methods, and therapeutics comprising cells produced using these methods are also disclosed.

The present invention relates in part to nucleic acids encoding proteins, nucleic acids containing non-canonical nucleotides, therapeutics comprising nucleic acids, methods, kits, and devices for inducing cells to express proteins, methods, kits, and devices for transfecting, gene editing, and reprogramming cells, and cells, organisms, and therapeutics produced using these methods, kits, and devices. Methods for inducing cells to express proteins and for reprogramming and gene-editing cells using RNA are disclosed. Methods for producing cells from patient samples, cells produced using these methods, and therapeutics comprising cells produced using these methods are also disclosed.